Evidence suggests that contemporaneous labour force participation affects cognitive function; however, it is unclear whether it is employment itself or endogenous factors related to individuals’ likelihood of employment that protects against cognitive decline.
Using AI and data, there is an opportunity to accelerate medical research in early diagnosis, leading to better prevention and treatment of disease. Within 15 years better use of AI and data could result in over 50,000 more people each year having their cancers diagnosed at an early rather than late stage.
Dementia is a syndrome – usually of a chronic or progressive nature – that leads to deterioration in cognitive function (i.e. the ability to process thought) beyond what might be expected from the usual consequences of biological ageing. It affects memory, thinking, orientation, comprehension, calculation, learning capacity, language, and judgement.
University of Toronto and MIT researchers have discovered important differences between lower-income and higher-income children in their ability to use “working memory,” a key brain function responsible for everything from remembering a phone number to doing math in your head.
Neurological conditions include everything from sudden onset conditions such as stroke or traumatic brain injury; to progressive, degenerative conditions such as Alzheimer’s disease; and intermittent conditions such as epilepsy and headache disorders.
At the Parkinson’s Foundation, one of our goals is to raise Parkinson’s disease (PD) awareness and how the Foundation supports those living with the disease and their loved ones. If you are familiar with Parkinson’s you probably know most of the items on this list, but we encourage you to share this article with someone who may not be familiar.
The World Alzheimer Report 2021 includes over 50 essays from leading experts from around the world and is supported by findings from 3 key global surveys, which received responses from 1,111 clinicians, 2,325 people with dementia and carers, and over 100 national Alzheimer and dementia associations.
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
We humans are deeply social creatures, and even after the disruption comes to an end, history tells us that the ghost of COVID-19 will stay with us for much longer. This is the long tail of COVID-19 – an increased mental health burden that will be felt the world over and must be addressed in concert with the virus itself if we are to emerge from this crisis stronger, more resilient, and more connected.
Cognitive-behavioural therapy is essential to building long-term mental fitness, and gamification is proven to drive engagement. This session looks at how to gamify CBT to help consumers build long-term mental wellbeing, the need to develop for specific market segments like older
As innovation redefines healthcare and life sciences as never before, investment continues to play a crucial role in driving transformation – so where do digital health’s leading investors see opportunity? Has the digital health investment cycle reached and passed its peak? What market challenges continue to impede commercialisation and ROI of digital health innovation? And of course, what will be the impact of COVID-19? A panel of leading investors discuss and debate the developing digital health investment landscape, emergent investment and exit strategies, and future capital and deal-flow.
© 2023 Neurometry Ltd. All rights reserved.